|
Clinical Intervention: Early-Phase (I/II) Clinical or Translational Trials
Contributing journals to this collection:
Cancer Prevention Journals Portal,
Cancer Prevention Journals Portal Content,
,
Cancer Reviews Online,
Molecular Cancer Research,
Cancer Prevention Research,
Molecular Cancer Therapeutics,
Cancer Research,
Cancer Reviews Online Content,
Clinical Cancer Research,
and Cancer Epidemiology Biomarkers & Prevention
Citations 31-38 of 38 total displayed.
- Research Articles
Single-Dose and Multiple-Dose Administration of Indole-3-Carbinol to Women: Pharmacokinetics Based on 3,3'-Diindolylmethane
- Gregory A. Reed, Dora W. Arneson, William C. Putnam, Holly J. Smith, John C. Gray, Debra K. Sullivan, Matthew S. Mayo, James A. Crowell, and Aryeh Hurwitz
Cancer Epidemiol. Biomarkers Prev. 2006; 15: 2477-2481.
[Abstract]
[Full text]
[PDF]
- Research Articles
Effect of a 12-Month Exercise Intervention on Patterns of Cellular Proliferation in Colonic Crypts: A Randomized Controlled Trial
- Anne McTiernan, Yutaka Yasui, Bess Sorensen, Melinda L. Irwin, Angela Morgan, Rebecca E. Rudolph, Christina Surawicz, Johanna W. Lampe, Kamran Ayub, John D. Potter, and Paul D. Lampe
Cancer Epidemiol. Biomarkers Prev. 2006; 15: 1588-1597.
[Abstract]
[Full text]
[PDF]
- Research Articles
A Phase I Study of myo-Inositol for Lung Cancer Chemoprevention
- Stephen Lam, Annette McWilliams, Jean leRiche, Calum MacAulay, Lee Wattenberg, and Eva Szabo
Cancer Epidemiol. Biomarkers Prev. 2006; 15: 1526-1531.
[Abstract]
[Full text]
[PDF]
- Cancer Therapy: Clinical
Fenretinide Activity in Retinoid-Resistant Oral Leukoplakia
- Scott M. Lippman, J. Jack Lee, Jack W. Martin, Adel K. El-Naggar, Xiaochun Xu, Dong M. Shin, Margaret Thomas, Li Mao, Herbert A. Fritsche, Jr., Xian Zhou, Vassiliki Papadimitrakopoulou, Fadlo R. Khuri, Hai Tran, Gary L. Clayman, Walter N. Hittelman, Waun Ki Hong, and Reuben Lotan
Clin. Cancer Res. 2006; 12: 3109-3114.
[Abstract]
[Full text]
[PDF]
- Cancer Prevention
Pilot Study of Oral Silibinin, a Putative Chemopreventive Agent, in Colorectal Cancer Patients: Silibinin Levels in Plasma, Colorectum, and Liver and Their Pharmacodynamic Consequences
- Carmen Hoh, David Boocock, Tim Marczylo, Rajinder Singh, David P. Berry, Ashley R. Dennison, David Hemingway, Andrew Miller, Kevin West, Stephanie Euden, Giuseppe Garcea, Peter B. Farmer, William P. Steward, and Andreas J. Gescher
Clin. Cancer Res. 2006; 12: 2944-2950.
[Abstract]
[Full text]
[PDF]
- Epidemiology and Prevention
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof-of-Principle Study
- Saverio Bettuzzi, Maurizio Brausi, Federica Rizzi, Giovanni Castagnetti, Giancarlo Peracchia, and Arnaldo Corti
Cancer Res. 2006; 66: 1234-1240.
[Abstract]
[Full text]
[PDF]
- Cancer Prevention
Celecoxib Decreases Ki-67 Proliferative Index in Active Smokers
- Jenny T. Mao, Michael C. Fishbein, Bradley Adams, Michael D. Roth, Lee Goodglick, Longsheng Hong, Marie Burdick, E. Robert M. Strieter, Carmack Holmes, Donald P. Tashkin, and Steven M. Dubinett
Clin. Cancer Res. 2006; 12: 314-320.
[Abstract]
[Full text]
[PDF]
- Cancer Prevention
Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals
- H-H. Sherry Chow, Iman A. Hakim, Donna R. Vining, James A. Crowell, James Ranger-Moore, Wade M. Chew, Catherine A. Celaya, Steven R. Rodney, Yukihiko Hara, and David S. Alberts
Clin. Cancer Res. 2005; 11: 4627-4633.
[Abstract]
[Full text]
[PDF]
|
|
Collected Resources Home
|
|
|
|